FT : Orange chief hopeful of sector turnround

Orange chief hopeful of sector turnround

Orange chairman and chief executive Stéphane Richard
Stéphane Richard, Orange chairman and chief executive
After years of being squeezed by a price war of unprecedented severity and the grip of regulations, Stéphane Richard, chief executive of Orange, can afford himself some hope for the years ahead.
“We are higher than Free’s arrival two years ago. I am happy with this position,” Mr Richard said, alluding to a period when the arrival of a fourth, cut-price competitor in France’s mobile market sent prices – as well as Orange’s shares – spiralling downwards.

A share price recovery has been helped by extensive cost cutting at Orange, something Mr Richard is committed to maintain with no plans to replace many of the 30,000 employees set to retire in the next few years.
But, more importantly, investors have begun to take greater interest in Orange due to the evolving competitive situation in European telecoms. Mr Richard believes Orange, and perhaps the rest of European market, has reached the cyclical nadir. The French price war might well be over.
“We are at the end of the cycle. We have had massive price cuts in the French market – 30 per cent on average in mobile contracts – so we are now at the low of the lowest in Europe. At a level not sustainable for some of the players for long.”
This, he predicts, will mean further consolidation in the French telecoms market to follow the merger deal between SFR and Numericable.
“Bouygues is facing a real challenge. In my view, they have a standalone plan, but that will probably lead them to restructuring the company massively with quite a social impact,” he said.
“So I understand that they would also look at other options including finding an understanding with the other players such as network sharing or a merger. I think they are still assessing the options, but they need to make a decision quite quickly.”
The merger between SFR and Numericable would have a “limited indirect impact” on Orange’s wholesale revenues, since the mobile operator would have less need to use its fixed line network. But he is not worried about increased competition from the merged group, even if he will seek to level the regulatory position with competition authorities.
“SFR and Numericable will be a powerful convergent player. SFR is a good brand, much better than Numericable, but Orange will remain the leader in all the markets.”
More broadly, Mr Richard detects a change in tone among European politicians about the telecoms sector, which has been hamstrung by restrictions on mergers as well as cuts to revenues from roaming and connections, according to executives.
He said the telecoms sector was no longer regarded as just a “mine for taxes” but something that needed to be nurtured to ensure global competitiveness. This view has been reinforced by recent support for telecoms consolidation by European Commission presidency hopeful Jean-Claude Juncker and German leader Angela Merkel.
Orange to protest against Numericable-SFR deal


Orange, France’s largest telecoms group, will complain to the competition authorities about tax and regulatory concerns caused by the merger between Numericable and SFR, its Vivendi-owned rival, write Daniel Thomas and Adam Thomson .
The £14bn deal will be the start of a period of French telecoms consolidation, according to Stéphane Richard, chief executive, as companies battle to survive a drop in prices over the past two years.
Read more
While French politicians failed to block the takeover deal by Numericable of SFR, there is a tide of opinion that the decision to introduce a fourth operator into the market was a mistake and should be reversed.
Mr Richard has, however, been “relatively disappointed” by the overall package of telecoms reforms overseen by Neelie Kroes, Europe’s digital commissioner. He hopes that the next commissioner following the elections in May will be more supportive of building a strong telecoms sector for the digital economy of Europe.
Mr Richard’s own position as chief executive of Orange was extended last month by the board, which is expected to be ratified by shareholders at the company’s general meeting.
He is still under investigation in a long-running fraud inquiry involving businessman Bernard Tapie when he was chief of staff of former French finance minister Christine Lagarde. “I reject clearly and totally the accusations regarding my personal involvement in this matter,” he said, adding that there was no update on the investigation.
He said that he was not worried about the outcome of the inquiry, although he noted that he “would not advise any friends to take a position in the government” in future as “it becomes really risky”.
Orange is, however, coming to an end of its bombastically named “Conquest 2015” strategic plan, which he admits will fall short in a couple of areas but only as a result of the unexpected changes in the telecoms market in the period.
For example, an objective to reach 300m customers in the emerging markets will probably miss by 20m-30m, but he says that the right objectives were addressed in the plan such as network improvement, 4G rollout and employee conditions.
“We have made a lot of progress, probably not as much as we would have liked. But the situation with the industry in Europe and big change in French market can explain that we were not position to do as much as we could have done.”
Meanwhile, the long-mooted merger of Deutsche Telekom and Orange has not moved closer to being a reality, even if Mr Richard points out that the narrowing of the valuations between the two would make it easier.
“It is clearly not an option in the short term, not because of competition but because of the current situation of both companies. Also, market values of both companies would make it difficult to have merger of equals, which would need to be a precondition.
“Now, with the recent recovery in share price, the gap has reduced a lot . . . but still not in the right ratio But you can have some changes; if they sell the US business to Sprint, it can change the situation.”

CNN : Activist: Pepsi CEO has made a 'major mistake'

Nelson Peltz's Trian is stepping up its fight against Pepsi's Indra Nooyi. She's built a "culture of sycophants."

FORTUNE -- The battle between Pepsi and famed investor Nelson Peltz is fizzing over.
Ed Garden, the chief investment officer of Peltz's Trian Fund management, says Pepsi's CEO Indra Nooyi has mismanaged the company and had built a "culture of sycophants."
"What they need are honest, dynamic managers," says Garden. "Instead they have a spin-machine."
Peltz got interested in Pepsi (PEP) about a year ago, and his firm now owns just under 1% percent of the company, worth around $1 billion. Earlier this year, he proposed a plan to break up Pepsi by splitting up its beverage and snack divisions. Pepsi rejected the plan a little over a month ago. Peltz has since fired back that they didn't give his idea enough thought.
Now it appears Peltz is going on the attack against Nooyi. On Wednesday, speaking at the SALT hedge fund conference in Las Vegas, Garden said Nooyi is "suffocating" the company. Trian's main beef is that Pepsi spends $1.1 billion a year on management. Garden said that is mostly corporate waste. Breaking up the company would bring back focus and lower costs, he says.
More: Falling soda sales: Not a trend, but a fundamental shift
Many Pepsi defenders think Nooyi has done a good job. The stock is up 5% this year, which is better than the market. In its most recent quarter, Pepsi's profits were up 13%. Still, that doesn't seem to be enough to satisfy Peltz, who appears to be looking for a change at the top.
"The current CEO has made a major mistake," says Garden. "She's built a huge bureaucracy."

>>> EU's Barnier: Will examine legality of French decree on foreign takeovers un


EU's Barnier: Will examine legality of French decree on foreign takeovers under EU law
- French decree could be a possible limitation on free movement of capital 
- France must notify the measures to the EU 
- EU rules do permit protection of strategic and essential assets 
- National measures must not lead to protectionism 

**Note on May 14th (FR) France govt said to have issued decree to prohibit foreign takeover of strategic firms - financial press - France Industry Min Montebourg said the new 'blocking' measures (adding 5 sectors to the current 11) are considered strategic; considers Alstom as strategic - French press interview

NY Post : David Tepper says ‘The market is dangerous right now’

LAS VEGAS — Billionaire investor David Tepper, the irreverent hedge-fund manager who made more money last year than any of his peers, is getting nervous.
“The market is dangerous right now,” said Tepper, who gained a reputation in late 2008 for his prescient bet that US banks would survive the financial crisis. Last year, his $20 billion Appaloosa Management distressed-debt hedge fund earned a return of almost 40 percent, net of fees — enough to give Tepper a personal $3.5 billion payday.
But the good times could be coming to an end, he said, adding it’s “nervous time.”
Central banks are too complacent these days, Tepper said in a one-on-one interview here with Anthony Scaramucci, the founder of SkyBridge Capital at the SALT conference — the annual get-together of the hedge-fund sector’s heavy hitters that also draws movie stars and politicians, who mix it up with Wall Street’s brightest stars in the freewheeling atmosphere of this desert casino town.
Tepper said the European Central Bank “better ease in June” given the low level of inflation there. “If they don’t, it may be too late,” he warned.
While most of the financial world, and central bankers, have focused on inflation, he said deflation could be worse, pointing to the tepid economic growth more than five years after the financial crisis.
“I’m not saying go short,” he told the investors in the audience. “I’m just saying don’t be too frickin’ long right now.”
Tepper, known for his salty language, cleaned it up for the crowd until he told a story about how his fund’s recent winning streak followed his decision in 2008 to make sure all food banks, shelters and pantries in his home state of New Jersey had enough money to keep going.
“So you believe in karma?” asked Scaramucci.
“Are you f–king kidding me? Of course I believe in that sh-t” replied Tepper.
Tepper started his hedge fund in 1992 after a stint helping put Goldman Sachs’ junk bond operation on the map. The 56-year-old investor, who proudly touts his “inner city” roots, was considered too rough to be named partner. “I couldn’t stand that place,” he said, so he struck out on his own and starting lining up investors for a hedge fund.
An investor who gave him $1 million in 1992 would have $149 million today — one of the best returns in the industry.

>>> AstraZeneca board in line for GBP 60m windfall if Pfizer bid succeeds; Pfize

AstraZeneca board in line for GBP 60m windfall if Pfizer bid succeeds; Pfizer's top scientist to meet with Wellcome Trust 

AstraZeneca’s senior executives would be in line for a GBP 60m (EUR 73m) windfall if a takeover bid from rival pharmaceuticals group Pfizer succeeds, The Times reported. The report said AstraZeneca chief executive Pascal Soriot and 12 other senior executives at the FTSE-100 pharmaceuticals company stand to gain if options and share incentives mature due to a takeover, but did not cite a source for the claim.

Soriot holds options and shares valued at GBP 31m, while his senior colleagues together hold more than 0.5m shares, the item noted.

Separately, the report noted that Soriot said a takeover by Pfizer is “not inevitable". The CEO said AstraZeneca, which is fighting a GBP 63bn takeover by its US rival, is confident about its strategy for independence. AstraZeneca’s defence against Pfizer turned to the geographic challenges the combined company would face, as executives fronted up to Parliament’s Science and Technology Committee yesterday morning, this news service reported on Wednesday.

The Daily Telegraph reported that Pfizer’s leading scientist Mikael Dolsten is visiting the UK to hold meetings with members of the country’s science community. It is understood that Dolsten held a meeting yesterday, 14 May with the chairman of the Wellcome Trust, William Castell, the item said. Dolsten also intends to hold a meeting with the president of the Royal Society, Paul Nurse, the article added, noting that both Nurse and Castell have voiced concerns about Pfizer’s bid for AstraZeneca.

In the meantime, AstraZeneca continued its recent campaign to update the market on the health of its drug pipeline. Below is an excerpt from a company announcement, the full version of which can be read here.

New data from AstraZeneca's investigational cancer medicines demonstrate the rapid progression of its oncology pipeline. Over 40 scientific abstracts from AstraZeneca and its global biologics R&D arm MedImmune will be featured at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) at the end of this month.

Briggs Morrison, Executive Vice President, Global Medicines Development and Chief Medical Officer at AstraZeneca said: "We believe that our rich oncology pipeline has the potential to redefine the way that cancer patients are treated. We continue to deliver on our late stage assets and drive our scientific leadership in oncology, as clearly demonstrated by the recent accelerated development of key assets.

"The preliminary data made available today highlight our strength across our three core areas of oncology research: immuno-oncology, our focus on the genetic drivers of cancer and acquired resistance and DNA damage repair. We are looking forward to the presentation of the full data sets at ASCO."


Source The Times (London), Daily Telegraph, Company website

>>> Alstom: government working on French consortium including CDC, Areva, Thales

Alstom: government working on French consortium including CDC, Areva, Thales and Safran; Thales rejects claim – reports (translated)

The French government is understood to be trying to set up an alternative to the proposed EUR 12.35bn sale of the energy operations of Alstom to listed Connecticut-based conglomerate General Electric (GE), French weekly La Lettre de L’Expansion reported. The unsourced report said that French Finance and Economy Minister Arnaud Montebourg is believed to be busy creating a consortium of French companies that could involve industrial groups Areva, Thales and Safran, as well as state-owned financial services group Caisse des Depots et Consignations (CDC). The report claimed that Thierry Breton has been acting as the adviser to Montebourg on that matter.

This development was also reported in daily Les Echos, which referred to comments made by Thales chairman and chief executive Jean-Bernard Levy, who denied that his group was involved in the matter and that Montebourg had contacted Thales.

He then added that Thales was looking for opportunities to acquire businesses, especially companies operating in the railway signaling sector.


Source La Lettre de l'Expansion, Les Echos

>>> What to look at today

US Market closed Lower, Small cap leaded the move ( Russel 2000 -1,6%), Out of the five largest sectors that represent more than 70.0% of the S&P500, consumer discretionary (-1.1%), financials (-0.8%), technology (-0.6%), and industrials (-0.8%) lagged throughout the session, while health care (unch) displayed relative strength thanks to modest gains in biotech. The iShares Nasdaq Biotechnology ETF (IBB 231.41, +0.90) advanced 0.4%. The weakest sector of the day—consumer discretionary—suffered from noteworthy losses among apparel retailers. Shares of Fossil (FOSL 100.00, -11.45) tumbled 10.3% after the company's cautious guidance overshadowed its earnings beat. Volume were belwo average @ 600mil shares... Japan Q1 GDP grew at a 3-year high of 5.9% on annual basis, as consumers rushed to make advance purchases before the Apr 1st start of higher sales tax and businesses invested generously...- Shanghai Composite remains under pressure on renewed concerns over China's
rate of growth in the wake of disappointing April economic data. China National...Nikkei -1,07% HS+0,35%...Shanghai -0,70%

Eur$ S&P Fut flat European fut -0,10%

Macro
- French Govt Publishes Decree on Foreign Investment, French Decree Lets Govt Block Some Foreign Takeovers

Keep an eye on :
- AN FP : Mediaset Seeks Financing to Boost Canal+ Stake, Expansion Says
- AGL IM : Autogrill PT Cut to EU8.5 at Mediobanca; Kept at Outperform
- AGN NA : Aegon 1Q Underlying Pre-Tax Profit Beats Analysts' Estimates
- CFR VX : Richemont FY Oper. Profit In Line With Ests. April Sales Hurt by Japan, Div. Beats Forecast
- G IM : Generali 1Q Net Income Rises to EU660m; Beats EU606.1m Estimate
- IM NA : Imtech 1Q Net Loss EU77.7m vs EU60.9m Loss
- LNZ AV : Lenzing 1Q Sales, Ebit Drop; Cost Cut Program Exceeding Target
- M5Z GY : Manz 1Q Sales Rise 9%, Loss Widens; Says Got New Orders of EU75m
- MRK GY : Merck KGaA 1Q Rebif Sales Beat Ests.; Erbitux Sales Miss
- UG FP : Peugeot Family Won’t Withdraw From Carmaker, Member Tells Echos
- SIX2 GY : Sixt 1Q Sales Rise 8%; Pretax Up 19%; Confirms 2014 Outlook
- SZG GY : Salzgitter 1Q Loss EU13.3m vs EU17.1m Loss, Confirms Forecast
- TKA AV : America Movil Starts Public Offer in Cash for Telekom Austria
- VIV FP : Vivendi 1Q Sales in Line, Adj. Net Income Beats Estimates, 1Q Adj. Net Beats, Says It's Primed for Growth
- VK FP : Vallourec to Cut 240 Jobs in France, Germany: Les Echos
- VTG LN : VTG 1Q Sales, Ebit, Pretax Fall; Cuts 2014 Sales Outlook
- WDI GY : Wirecard 1Q Sales Miss Est., Ebitda Up 33%; Confirms Outlook
- ZURN VX : Zurich Insurance 1Q Net $1.27b vs $1.06b